Extensions to the visual predictive check to facilitate model performance evaluation. - Wikidata - awgldk - TriplyDB

Extensions to the visual predictive check to facilitate model performance evaluation.

Extensions to the visual predictive check to facilitate model performance evaluation.

http://www.wikidata.org/entity/Q42947696

about

Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients The pharmacokinetics of methadone and its metabolites in neonates, infants, and children Artificial pancreas: model predictive control design from clinical experience Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.The present and future of withdrawal period calculations for milk in the European Union: focus on heterogeneous, nonmonotonic data.Calculation of a First-In-Man Dose of 7-O-Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs.Pharmacokinetic/Pharmacodynamic modeling of abexinostat-induced thrombocytopenia across different patient populations: application for the determination of the maximum tolerated doses in both lymphoma and solid tumour patients.Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968).Quantitative pharmacology approach in Alzheimer's disease: efficacy modeling of early clinical data to predict clinical outcome of tesofensine.Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children.Missing data in model-based pharmacometric applications: points to consider.Tips and traps analyzing pediatric PK data.Explaining variability in ciclosporin exposure in adult kidney transplant recipients.Evaluation of different tests based on observations for external model evaluation of population analyses.Automatic data binning for improved visual diagnosis of pharmacometric models.Covariates of intravenous paracetamol pharmacokinetics in adults Modeling of age-dependent amyloid accumulation and γ-secretase inhibition of soluble and insoluble Aβ in a transgenic mouse model of amyloid deposition.Population pharmacokinetics of abacavir in pregnant women.Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients.Population PK/PD analysis of metformin using the signal transduction model.Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.The relationship between fluticasone furoate systemic exposure and cortisol suppression.Estimation of renal cell carcinoma treatment effects from disease progression modeling Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies.Population Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease.Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.Population pharmacokinetic analysis of varenicline in adult smokers.A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects Population pharmacokinetic analysis of lanicemine (AZD6765), an NMDA channel blocker, in healthy subjects and patients with major depressive disorder.Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers.Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.A population pharmacokinetic model of AT9283 in adults and children to predict the maximum tolerated dose in children with leukaemia.Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.Oral morphine dosing predictions based on single dose in healthy children undergoing surgery.Pharmacokinetics and analgesic effectiveness of intravenous parecoxib for tonsillectomy ± adenoidectomy.

P2860

Q27674362-5D15EE72-596D-4F72-B2D6-B05C3B9D9D5E Q28272907-BACFDEA7-AA83-4654-8E23-91930BA63D6A Q30393865-C8278D89-68F5-4611-9C22-F3DCC47EA2CF Q30409808-D9081437-1CDE-4647-AE08-571B20664DBB Q30499990-9EB2C8B7-47EE-4DAE-8F8A-20E7CB4CF4AC Q31127244-D96BAD24-BCE7-4784-8010-7C6EB1DAFC10 Q31172628-781F1184-844C-40E1-934F-9DDC546C0249 Q33415594-4AC46986-9931-4C15-B00F-1FFE9BA0EB20 Q33419744-EE32195A-37FA-43A0-9F10-FFF801086004 Q33524423-1DE22B97-5CF5-46E8-BDBB-5EC7632B3462 Q33574626-AF433327-5438-4862-A556-992F54A208E5 Q33706156-889075C2-18BD-4EF7-B931-51C6745FD815 Q33820152-2E0D3D50-9905-4C6E-8676-EB045DE7D445 Q33847140-49113384-BA5F-44D6-9523-EA4BFCA08FCB Q33869167-36BEC731-61EE-4398-A01A-E285DC663766 Q34063375-443486F2-E2B3-4BB7-86AB-1AE29359E56A Q34193839-D2A37D69-FCBE-4F48-A3D8-D38881FF63C7 Q34292546-D24ED16D-84BD-44BF-B7D8-4474A2F74423 Q34299084-5EF9178E-ADCE-496E-B8BA-53FA3DB5B178 Q35138216-3A61AEC8-8E46-4B47-8210-152240E4CBA5 Q35183631-F8A9398A-FE45-475C-A4CB-9D1936E23BBD Q36112215-6EC50A5A-9DBC-415C-A2AC-86279851FD3E Q36390254-26525FBB-72A5-4D65-914A-DE781ADC8C86 Q36941579-ED35369F-B1A9-42C2-AAD5-3D99FA2A6BDD Q37053876-F04B261C-0C95-413D-87C4-6B0E6C2F073A Q37188226-0ECD9FBE-0FE7-47AF-9ECB-3A9697FB5FD7 Q37217573-85C5294A-B279-411A-9098-22B9D07D9632 Q37322523-10C695EE-2DBC-44F0-B255-89A23059624C Q37429593-6653D870-9170-4A9F-B944-239552418137 Q37470692-8E0DE02A-9609-4ED2-9538-34BF9750958E Q37471047-55FD17BE-A7D3-4AF7-9877-B2B5A98C959F Q37635200-79DFEB83-1580-4891-B54E-A12B9E82A563 Q38802855-8344564F-9975-4D79-B8C3-5CC91EE7F1DC Q38856871-962DD9AF-34B2-4527-A26A-5CC27643AA62 Q38880620-B86D72E3-773C-486C-974C-BC1812D87378 Q38948892-D3ACC5F9-2487-48FE-AA5C-76B1A947E377 Q38972542-97F56CD1-5AF6-4EC0-86C3-FB007F08D1B4 Q39124257-7DADA29B-AFBE-4C27-B519-23D76A17F996 Q39251483-B317F1CD-8C78-47A3-871E-DC296C7E61D8 Q39251488-B8F2170E-DA70-4DF3-A503-0148BE6048FB

P2860

Extensions to the visual predictive check to facilitate model performance evaluation.

http://www.wikidata.org/entity/Q42947696

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Extensions to the visual predictive check to facilitate model performance evaluation.

@en

Extensions to the visual predictive check to facilitate model performance evaluation.

@nl

type

label

Extensions to the visual predictive check to facilitate model performance evaluation.

@en

Extensions to the visual predictive check to facilitate model performance evaluation.

@nl

prefLabel

Extensions to the visual predictive check to facilitate model performance evaluation.

@en

Extensions to the visual predictive check to facilitate model performance evaluation.

@nl

P1433

Q42947696-17BB2F21-D091-447D-AB9B-5E03F8759440

P1476

Q42947696-C8085423-72CA-432D-BC94-70A04B4FF698

P2093

Q42947696-1DE212A2-1930-464E-87F9-090695AB7F4B

Q42947696-2331D7F2-2A01-40A7-BDB4-48ACC2FFD03B

Q42947696-5FCD508E-B6C0-456F-92F4-60F39A0824AD

Q42947696-7B51AC83-B03C-4643-86F5-4C720F8F6C06

P2860

Q42947696-0DB1C5CA-3E0E-4F04-8908-E971AB45CA56

Q42947696-15CBAD5F-2A95-4B5F-B699-8EAD3C22D859

Q42947696-1A5D8CB9-D2AF-4C4B-BE83-34767605522E

Q42947696-3D7296C9-8A78-4795-8970-AB7577531904

Q42947696-66FB8685-4DBF-4605-8C12-F1DC3F13BAB7

Q42947696-79C62945-25B2-430D-B1B6-045E2E262052

Q42947696-85FF3069-A6D4-4173-B3F4-A01188B790F9

Q42947696-8E2119EB-2E7C-4C21-87EB-C661A5B2D740

Q42947696-8FFAAFAE-4E4E-4796-BB43-72AED6C95FF3

Q42947696-9AFAF242-CDE6-4575-9E7A-5C9EB4204C5B

P2888

Q42947696-9AFB96A4-0B05-4DEC-909D-9964EBBC89C4

P304

Q42947696-2838A718-808B-49BA-84D7-B864F902B553

P31

Q42947696-6743E9F9-4643-43E5-9BE8-E4901D78FE68

P356

Q42947696-BAE37AC6-A191-4EB0-BE70-91F735FBD26A

P433

Q42947696-119F0756-BEBA-4C9F-8500-BEEE3ACD5B5E

P478

Q42947696-DB40A6C6-9D66-4795-994D-33694172410A

P577

Q42947696-DFEB8C90-C1D3-404E-A19E-904292E79B01

P5875

Q42947696-CBEEF48B-FB24-40AF-8FC3-795336773287

P698

Q42947696-CBF7FCAA-6459-4DF1-AA71-942641D24746

P932

Q42947696-03577045-DEF1-461A-A332-3B0961387AC4

P356

S10928-007-9081-1

P1433

Journal of Pharmacokinetics and Pharmacodynamics

P1476

Extensions to the visual predictive check to facilitate model performance evaluation.

@en

P2093

Bart A Ploeger

http://www.w3.org/2001/XMLSchema#string

Jan I Freijer

http://www.w3.org/2001/XMLSchema#string

Meindert Danhof

http://www.w3.org/2001/XMLSchema#string

Teun M Post

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data.

A joint model for nonlinear longitudinal data with informative dropout.

Multiple imputation for model checking: completed-data plots with missing and latent data.

Pharmacokinetic/pharmacodynamic modeling in drug development.

Drug treatment effects on disease progression.

A new equivalence based metric for predictive check to qualify mixed-effects models.

Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.

Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.

Model-based drug development.

Learning versus confirming in clinical drug development.

P2888

s10928-007-9081-1

P304

185-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10928-007-9081-1

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5654992

http://www.w3.org/2001/XMLSchema#string

P698

18197467

http://www.w3.org/2001/XMLSchema#string

P932

2798054

http://www.w3.org/2001/XMLSchema#string